Attached files
| file | filename |
|---|---|
| S-1 - REGISTRATION STATEMENT - TENAX THERAPEUTICS, INC. | oxbt_s1.htm |
| EX-3.5 - CERTIFICATE - TENAX THERAPEUTICS, INC. | oxbt_ex35.htm |
| EX-3.4 - CERTIFICATE - TENAX THERAPEUTICS, INC. | oxbt_ex34.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-1, filed on the date hereof, of Oxygen Biotherapeutics, Inc. formerly Synthetic Blood International, Inc. (a development-stage enterprise) (the “Company”) of our report dated July 24, 2012 with respect to the consolidated financial statements of the Company included in the Company’s Annual Report on Form10-K, for the year ended April 30, 2012, filed on July 24, 2012.
/s/ Cherry Bekaert LLP
(formerly named Cherry, Bekaert & Holland, L.L.P.)
Raleigh, North Carolina
March 22, 2013